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~5]  Serum biomarkers in CF lung disease 
M.S. Muhlebach 1 , B. Button 2, M.W Leigh 1 , R.C. Boucher 2. 1Dept. of Pediatrics, 
2Medicine, University of North Carolina, Chapel Hill, USA 
This study aims to discover serum biomarkers that are sensitive nough to detect 
short term changes or track changes in lung disease in patients who cannot perform 
spirometry. 
Methods: Serum was obtained from 22 patients at initiation and completion of 
intravenous antibiotic therapy for pulmonary exacerbations. A cross-sectional study 
included 202 patients (age 3 30 yrs) who ranged in severity of lung disease. 
After enrichment by affinity depletion, serum proteins were separated by 2D-gel 
electrophoresis (pI 5 8, MW 6 250 kD). Intensity and presence vs. absence of 
detected features (MCI) was compared by pair wise analyses in pre- vs. post- 
antibiotic samples and using regression analyses for the cross-sectional study. 
Results: On average 1434 protein features were identified per gel. Twenty MCIs 
were significantly (p < 0.005) different in pre- versus post- therapy and were present 
in 90 100% of all gels. Proteins correlating with improvement in lung function were 
mostly inflammatory/acute phase reactants (e.g. complement C4, hemopexin). Other 
MCIs, which may be detected as evidence of proteolysis (e.g. Ig Lambda), decreased 
during therapy. Patients with clinical but insufficient pulmonary improvement 
showed more changes in proteins related to nutritional function (e.g. retinol binding 
protein). The cross-sectional study revealed 18 MCI that were present in >80% of 
gels and correlated with FEV1. Many of these were different MCIs than in the pre- 
post-study and had never been described in CF (e.g. afamin, tetranectin). 
Conclusion: 2D-gel electrophoreses identified patterns of proteins that correlate 
with short term changes in lung function. Many proteins were related to inflamma- 
tion but could be useful in a panel of markers to follow pulmonary improvement 
in patients unable to do spirometry. 
5. Immunology pulmonology 
~]  Correlation of six-minute walk distance with other clinical 
paramaters in adult Cystic Fibrosis patients 
L. Fila 1 , J. Musil 1 , D. Zemkova 2. 1Department ofPneumology, 2Department of
Pediatrics' of Charles University 2nd School of Medicine and University HosTital 
Motol, Prague, Czech Republic 
Aims: to correlate six-minute walk distance (6MWD) with other clinical parameters 
in adult cystic fibrosis (CF) patients. 
Methods: six-minute walk test (6MWT) in stable adult CF patients was performed 
according to ATS guidelines (2002) and 6MWD was correlated with pulmonary 
function (FEV1), chest X-ray score (Northern), clinical score (Schwachman- 
Kulczycki) and nutritional status (body mass index; BMI) by using Spearman 
correlation coefficient (p < 0.05 was considered as significant). 
Results: 52 adult CF patients (30 M, 22 F) aged 25.0±4.5 years (mean±SD) were 
examined. 6MWD (615±61 m) was significantly correlated with FEV 1 (64±23% 
pred.), Schwachman clinical score (75± 15), Northern chest X-ray score (8±3) and 
BMI (20.5±2.1 kg/m2), as shown in Table 1. 
Conselusions: 6MWT is useful exercise test in adult CF patients and 6MWD is 
significantly correlated with other clinical parameters. 
Table 1. Correlation of 6MWD with other clinical parameters 
Parameter rs p 
FEV1 0.617 <0.001 
Schwachma~Kulczycki score 0.774 <0.001 
Northern score 0.619 <0.001 
BMI 0.368 0.008 
~6]  Progression of lung disease on pulmonary function tests (PFT) 
and high-resolution computed tomography (HRCT) in children 
and adolescents with Cystic Fibrosis 
E. Hatziagorou 1 , A. Oikonomou 2, F. Kirvasilis 1, M. Mantatzis 2, R Prassopoulos 2, 
J. Tsanakas 1 . 13rd Paediatric Dept, Paediatric Pulmonology Unit, Hippokration 
HosTital, Thessaloniki; 2Dept of Radiology, Alexandroupolis HosTital, 
Alexandroupolis, Greece 
Background: In cystic fibrosis (CF), chronic bacterial infection and inflammation 
lead to progressive worsening in lung structure and function. 
Aim: To compare the ability of HRCT scores and PFTs to detect changes in CF 
lung disease in children and adolescents with CE 
Methods: Baseline and follow-up HRCT scans and PFTs (at a median interval 
of 31 months) were retrospectively studied in a cohort of 42 CF patients (mean 
age: 10.9 years). Their scans were scored using 5 scoring systems (Bhalla, Hell- 
bich, Santamaria, Brody, Oikonomou). PFTs results were expressed as percentage 
predicted. Chronic Pseudomonas eruginosa infection and nutrition (percentage of
ideal body weight %IBW) were also assessed. 
Results: All HRCT scores deteriorated significantly (p < 0.0001). FEV1 decreased 
by 3.5 annually (p < 0.05), while FVC, FEF25 75 and %IBW remained stable. 
Relationships between changes in HRCT scores and changes in FVC, FEV1 
and FEF25 75 were weak. Baseline chronic Pseudomonas infection correlated 
significantly with baseline HRCT scores (p<0.01), baseline FVC and FEV1 
(p < 0.05) and with the change in FVC and FEV1 (p < 0.05). Substantial structural 
lung damage and impaired lung function was evident in some children without 
chronic Pseudomonas infection. 
Conclusions: HRCT scan is more sensitive than PFTs, %IBW and chronic Pseu- 
domonas infection in the detection of early and progressive lung disease and may 
be useful in the follow-up of CF patients. 
• Repeatability of cardiorespiratory measurements recorded by the 
LifeShirt 
J.M. Bradley 1,2, L. Boyle 1 , I. Bradbury 2, J.S. Elborn 1 . 1Belftst City Hospital; 
2 University of Ulster, UK 
The LifeShirt offers a new non-invasive method of measuring the cardiorespiratory 
responses to activity. Aim: To assess the repeatability of the cardiorespiratory 
measurements recorded by the system. 
Methods: 20 stable patients with CF (G1) and 20 age matched healthy individuals 
(G2) were recruited [G1; 10M, age: 26 (9) yrs; G2; 10M, age: 24 (5) yrs]. All 
subjects wore the system during an endurance xercise test (6MWT) and a peak 
exercise test (modified shuttle test) on two occasions at least one week apart. Data 
relating to various cardiorespiratory parameters including: ViVol (inspiratory tidal 
volume); Ve (minute ventilation); RR (respiratory ate); heart rate and SpO 2 for the 
6MWT (mean values) and the modified shuttle test (peak values) were analysed. 
Analysis: t tests and repeated measures ANOVA assuming compound symmetry. 
Results: On both days performance on 6MWT and modified shuttle test was 
significantly greater in G2 vs G1. There was no significant difference between 
the days in exercise performance (6MWT or the modified shuttle test) in either 
group. When the groups were analysed together there were no differences in 
cardiorespiratory responses to exercise (Table 1). 
Outcome Modified shuttle test Mean 6MWT Mean Dif (95% CI) 
Dif (95% CI) 
ViVol (mL) 102.6 ( 433 to 228) 23.42 ( 74.6 to 27.75) 
Ve (L/min) 4.83 ( 19.32 to 9.65) 0.12 ( 2.01 to 1.78) 
RR (breaths/min) 1.35 ( 4.27 to 1.56) 0.08 ( 0.59 to 0.76) 
Heart rate (beats/min) 9.37 ( 19.6 to 0.86) 1.95 ( 0.40 to 4.30) 
SpO: (%) 3.13 ( 7.34 to 13.59) 0.21 ( 1.83 to 2.26) 
Conclusion: This study suggests that the cardiorespiratory measurements recorded 
by the LifeShirt system during endurance and peak exercise tests are repeatable. 
